365 related articles for article (PubMed ID: 21488084)
1. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein.
Lam HA; Wu N; Cely I; Kelly RL; Hean S; Richter F; Magen I; Cepeda C; Ackerson LC; Walwyn W; Masliah E; Chesselet MF; Levine MS; Maidment NT
J Neurosci Res; 2011 Jul; 89(7):1091-102. PubMed ID: 21488084
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway.
Wu N; Joshi PR; Cepeda C; Masliah E; Levine MS
J Neurosci Res; 2010 Jun; 88(8):1764-76. PubMed ID: 20029978
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine transmission is subtly modified in human A53Tα-synuclein overexpressing mice.
Platt NJ; Gispert S; Auburger G; Cragg SJ
PLoS One; 2012; 7(5):e36397. PubMed ID: 22570709
[TBL] [Abstract][Full Text] [Related]
4. Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats.
Creed RB; Roberts RC; Farmer CB; McMahon LL; Goldberg MS
Neurobiol Dis; 2021 Mar; 150():105246. PubMed ID: 33387634
[TBL] [Abstract][Full Text] [Related]
5. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
Richfield EK; Thiruchelvam MJ; Cory-Slechta DA; Wuertzer C; Gainetdinov RR; Caron MG; Di Monte DA; Federoff HJ
Exp Neurol; 2002 May; 175(1):35-48. PubMed ID: 12009758
[TBL] [Abstract][Full Text] [Related]
7. Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.
Cepeda C; André VM; Yamazaki I; Wu N; Kleiman-Weiner M; Levine MS
Eur J Neurosci; 2008 Feb; 27(3):671-82. PubMed ID: 18279319
[TBL] [Abstract][Full Text] [Related]
8. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
Peneder TM; Scholze P; Berger ML; Reither H; Heinze G; Bertl J; Bauer J; Richfield EK; Hornykiewicz O; Pifl C
Neuroscience; 2011 Apr; 180():280-92. PubMed ID: 21333719
[TBL] [Abstract][Full Text] [Related]
9. Decreased reuptake of dopamine in the dorsal striatum in the absence of α-synuclein.
Chadchankar H; Ihalainen J; Tanila H; Yavich L
Brain Res; 2011 Mar; 1382():37-44. PubMed ID: 21276428
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function.
Oaks AW; Frankfurt M; Finkelstein DI; Sidhu A
PLoS One; 2013; 8(4):e60378. PubMed ID: 23560093
[TBL] [Abstract][Full Text] [Related]
11. Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice.
Cepeda C; Hurst RS; Altemus KL; Flores-Hernández J; Calvert CR; Jokel ES; Grandy DK; Low MJ; Rubinstein M; Ariano MA; Levine MS
J Neurophysiol; 2001 Feb; 85(2):659-70. PubMed ID: 11160501
[TBL] [Abstract][Full Text] [Related]
12. Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit.
Tozzi A; de Iure A; Bagetta V; Tantucci M; Durante V; Quiroga-Varela A; Costa C; Di Filippo M; Ghiglieri V; Latagliata EC; Wegrzynowicz M; Decressac M; Giampà C; Dalley JW; Xia J; Gardoni F; Mellone M; El-Agnaf OM; Ardah MT; Puglisi-Allegra S; Björklund A; Spillantini MG; Picconi B; Calabresi P
Biol Psychiatry; 2016 Mar; 79(5):402-414. PubMed ID: 26392130
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine neurotransmission is altered in age- and region-specific manner in a Parkinson's disease transgenic mouse.
Medina-Luque J; Piechocinski P; Feyen P; Sgobio C; Herms J
Sci Rep; 2024 Jan; 14(1):164. PubMed ID: 38167878
[TBL] [Abstract][Full Text] [Related]
14. Synaptic dysfunction in Parkinson's disease.
Picconi B; Piccoli G; Calabresi P
Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
16. Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity.
Gaugler MN; Genc O; Bobela W; Mohanna S; Ardah MT; El-Agnaf OM; Cantoni M; Bensadoun JC; Schneggenburger R; Knott GW; Aebischer P; Schneider BL
Acta Neuropathol; 2012 May; 123(5):653-69. PubMed ID: 22361813
[TBL] [Abstract][Full Text] [Related]
17. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
[TBL] [Abstract][Full Text] [Related]
18. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation.
Matikainen-Ankney BA; Kezunovic N; Mesias RE; Tian Y; Williams FM; Huntley GW; Benson DL
J Neurosci; 2016 Jul; 36(27):7128-41. PubMed ID: 27383589
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.
Longo F; Mercatelli D; Novello S; Arcuri L; Brugnoli A; Vincenzi F; Russo I; Berti G; Mabrouk OS; Kennedy RT; Shimshek DR; Varani K; Bubacco L; Greggio E; Morari M
Acta Neuropathol Commun; 2017 Mar; 5(1):22. PubMed ID: 28292328
[TBL] [Abstract][Full Text] [Related]
20. Dopamine modulates release from corticostriatal terminals.
Bamford NS; Robinson S; Palmiter RD; Joyce JA; Moore C; Meshul CK
J Neurosci; 2004 Oct; 24(43):9541-52. PubMed ID: 15509741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]